IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
0.37
-1.21 (-76.58%)
At close: Sep 29, 2025, 3:59 PM
-76.58% (1D)
| Bid | 0.37 |
| Market Cap | 24.05M |
| Revenue (ttm) | 850K |
| Net Income (ttm) | -103.99M |
| EPS (ttm) | -1.58 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | -1.65 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 0.37 |
| Volume | 35,798,300 |
| Avg. Volume (20D) | 3,307,311 |
| Open | 0.35 |
| Previous Close | 1.58 |
| Day's Range | 0.32 - 0.48 |
| 52-Week Range | 0.32 - 2.79 |
| Beta | 0.41 |
| Ex-Dividend Date | n/a |
About IOBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IOBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IOBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
IO Biotech shares are trading lower after the FDA ...
Unlock content with
Pro Subscription
1 month ago
+68.75%
IO Biotech shares are trading higher following the release of its Q2 financial results.
1 month ago · seekingalpha.com
IO Biotech: A Buying Opportunity Following Phase 3 Readout In MelanomaIO Biotech's phase 3 melanoma trial showed a strong PFS benefit, especially in true 1st-line and PD1-negative patients, despite narrowly missing statistical significance. I believe the FDA should acce...
